Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sorin Avram

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Molecular Diversity|January 22, 2017
Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitorsLuminita Crisan, Sorin Avram, Liliana Pacureanu
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Structure-Based Identification of JAK1-Selective Candidates Using Ensemble Docking and Interaction AnalysisNicoleta Stoian, Sorin Avram, Liliana Halip
Molecular Informatics|September 11, 2025
Ligand B-Factor Index: A Metric for Prioritizing Protein-Ligand Complexes in DockingLiliana Halip, Cristian Neanu, Sorin Avram
Journal of Biomolecular Structure & Dynamics|March 29, 2020
Comprehensive investigation of selectivity landscape of glycogen synthase kinase-3 inhibitorsLiliana Pacureanu, Sorin Avram, Luminita Crisan
Journal of Chemical Information and Modeling|May 1, 2018
Modeling Kinase Inhibition Using Highly Confident Data SetsSorin Avram, Alina Bora, Liliana Halip, et al.
Journal of Environmental Biology|February 22, 2013
GIS utilization in determining the limits between low morphological unitsSorin Avram, Alina Vladut, Gheorghe Curcan, et al.
Molecular Informatics|January 17, 2020
Partial Least Squares Discriminant Analysis and 3D Similarity Perspective Applied to Analyze Comprehensively the Selectivity of Glycogen Synthase Kinase 3 InhibitorsLuminita Crisan, Sorin Avram, Ludovic Kurunczi, et al.
Bioorganic & Medicinal Chemistry|March 25, 2014
Exploring the biological promiscuity of high-throughput screening hits through DFT calculationsRamona Curpăn, Sorin Avram, Robert Vianello, et al.
Nature Reviews. Drug Discovery|April 4, 2025
Novel drug targets in 2024Sorin Avram, Liliana Halip, Ramona Curpan, et al.
Nature Reviews. Drug Discovery|April 2, 2024
Novel drug targets in 2023Sorin Avram, Liliana Halip, Ramona Curpan, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Molecular Diversity|January 22, 2017
Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitorsLuminita Crisan, Sorin Avram, Liliana Pacureanu
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
Structure-Based Identification of JAK1-Selective Candidates Using Ensemble Docking and Interaction AnalysisNicoleta Stoian, Sorin Avram, Liliana Halip
Molecular Informatics|September 11, 2025
Ligand B-Factor Index: A Metric for Prioritizing Protein-Ligand Complexes in DockingLiliana Halip, Cristian Neanu, Sorin Avram
Journal of Biomolecular Structure & Dynamics|March 29, 2020
Comprehensive investigation of selectivity landscape of glycogen synthase kinase-3 inhibitorsLiliana Pacureanu, Sorin Avram, Luminita Crisan
Journal of Chemical Information and Modeling|May 1, 2018
Modeling Kinase Inhibition Using Highly Confident Data SetsSorin Avram, Alina Bora, Liliana Halip, et al.
Journal of Environmental Biology|February 22, 2013
GIS utilization in determining the limits between low morphological unitsSorin Avram, Alina Vladut, Gheorghe Curcan, et al.
Molecular Informatics|January 17, 2020
Partial Least Squares Discriminant Analysis and 3D Similarity Perspective Applied to Analyze Comprehensively the Selectivity of Glycogen Synthase Kinase 3 InhibitorsLuminita Crisan, Sorin Avram, Ludovic Kurunczi, et al.
Bioorganic & Medicinal Chemistry|March 25, 2014
Exploring the biological promiscuity of high-throughput screening hits through DFT calculationsRamona Curpăn, Sorin Avram, Robert Vianello, et al.
Nature Reviews. Drug Discovery|April 4, 2025
Novel drug targets in 2024Sorin Avram, Liliana Halip, Ramona Curpan, et al.
Nature Reviews. Drug Discovery|April 2, 2024
Novel drug targets in 2023Sorin Avram, Liliana Halip, Ramona Curpan, et al.
Pageof 4